Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03473067 · ClinicalTrials.gov registry record · NA
Community Level Primary Prevention of Dating and Sexual Violence in Middle Schools
A NA study, sponsored by Lifespan.
- Completed
- Registry status
- NA
- Development phase
- 4,344
- Enrollment target
NCT03473067: Completed NA study, sponsored by Lifespan.
NCT03473067 is a NA study that has completed, run by Lifespan. The registered enrollment target is 4,344 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (209% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03473067, a NA study, has completed, sponsored by Lifespan.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,344 participants
- Enrollment target
Study Summary
Dating and sexual violence are significant public health concerns occurring on a continuum of severity across the lifespan, with serious consequences to victims and society. The present research advances the science of prevention by rigorously evaluating a comprehensive social norms marketing campaign to promote community-level change in dating and sexual violence in middle schools. Partnership between researchers and a CDC Rape Prevention and Education Program (RPE) funded agency is a core feature of this work, and aims to build community capacity to implement and evaluate violence prevention efforts, and promote the subsequent uptake of social norms marketing campaigns as a strategy for reducing dating and sexual violence among youth.
Primary Outcome
Rates of sexual violence victimization
Interventions
- BEHAVIORAL Social Norms Marketing Campaign
- OTHER Capacity Building
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,344 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
What the finished NCT03473067 record still lists
NCT03473067 is an interventional study that assigns participants to a tested intervention. Its 4,344 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (209% higher).
The record links to 0 conditions, and to 2 interventions - of which Social Norms Marketing Campaign is the first listed.
NCT03473067 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03473067 about?
NCT03473067 is a clinical study titled "Community Level Primary Prevention of Dating and Sexual Violence in Middle Schools". Dating and sexual violence are significant public health concerns occurring on a continuum of severity across the lifespan, with serious consequences to victims and society. The present research advances the science of prevention by rigorously evaluating a comprehensive social norms marketing campai...
What is the current status of trial NCT03473067?
This trial is currently completed. It is a NA study. The enrollment target is 4,344 participants. The study started on 2017-09-01. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03473067?
The interventions under investigation include: Social Norms Marketing Campaign (BEHAVIORAL), Capacity Building (OTHER).
Who is sponsoring clinical trial NCT03473067?
This trial is sponsored by Lifespan, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03473067's enrollment target sits among peer trials
4,344 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- NCT05543616 · 4,292 participants · Phase 2
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI